标题
Paracrine Effects of FGF23 on the Heart
作者
关键词
-
出版物
Frontiers in Endocrinology
Volume 9, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2018-06-08
DOI
10.3389/fendo.2018.00278
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Fibroblast growth factor 23 is related to profiles indicating volume overload, poor therapy optimization and prognosis in patients with new-onset and worsening heart failure
- (2018) Jozine M. ter Maaten et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Hepatic Production of Fibroblast Growth Factor 23 in Autosomal Dominant Polycystic Kidney Disease
- (2018) Frank Bienaimé et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Fibroblast growth factor 23 is induced by an activated renin–angiotensin–aldosterone system in cardiac myocytes and promotes the pro-fibrotic crosstalk between cardiac myocytes and fibroblasts
- (2018) Maren Leifheit-Nestler et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Fibroblast growth factor 23 is upregulated in the kidney in a chronic kidney disease rat model
- (2018) Hidekazu Sugiura et al. PLoS One
- FGF23 activates injury-primed renal fibroblasts via FGFR4-dependent signalling and enhancement of TGF-β autoinduction
- (2017) Edward R. Smith et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Kidney fibroblast growth factor 23 does not contribute to elevation of its circulating levels in uremia
- (2017) Maria L. Mace et al. KIDNEY INTERNATIONAL
- Vitamin D treatment attenuates cardiac FGF23/FGFR4 signaling and hypertrophy in uremic rats
- (2017) Maren Leifheit-Nestler et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Pleiotropic Actions of FGF23
- (2017) Reinhold G. Erben TOXICOLOGIC PATHOLOGY
- FGF23 is synthesised locally by renal tubules and activates injury-primed fibroblasts
- (2017) Edward R. Smith et al. Scientific Reports
- Genetic Ablation of Fgf23 or Klotho Does not Modulate Experimental Heart Hypertrophy Induced by Pressure Overload
- (2017) Svetlana Slavic et al. Scientific Reports
- Up-regulation of FGF23 release by aldosterone
- (2016) Bingbing Zhang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Fibroblast growth factor 23 is associated with left ventricular hypertrophy, not with uremic vasculopathy in peritoneal dialysis patients
- (2016) Margarida Sarmento-Dias et al. CLINICAL NEPHROLOGY
- The role of fibroblast growth factor 23 and Klotho in uremic cardiomyopathy
- (2016) Alexander Grabner et al. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
- Enhanced FGF23 production in mice expressing PI3K-insensitive GSK3 is normalized by β-blocker treatment
- (2016) Abul Fajol et al. FASEB JOURNAL
- Counter-regulatory paracrine actions of FGF-23 and 1,25(OH)2D in macrophages
- (2016) Xiaobin Han et al. FEBS LETTERS
- Genetic insights into the mechanisms of Fgf signaling
- (2016) J. Richard Brewer et al. GENES & DEVELOPMENT
- Fibroblast growth factor 23 directly targets hepatocytes to promote inflammation in chronic kidney disease
- (2016) Saurav Singh et al. KIDNEY INTERNATIONAL
- Update on FGF23 and Klotho signaling
- (2016) Reinhold G. Erben MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Extrarenal effects of FGF23
- (2016) Dieter Haffner et al. PEDIATRIC NEPHROLOGY
- Klotho modulates FGF23-mediated NO synthesis and oxidative stress in human coronary artery endothelial cells
- (2016) Beatrice Richter et al. PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
- Fibroblast Growth Factor 23 Is Associated With Subclinical Cerebrovascular Damage
- (2016) Clinton B. Wright et al. STROKE
- Therapeutics Targeting FGF Signaling Network in Human Diseases
- (2016) Masaru Katoh TRENDS IN PHARMACOLOGICAL SCIENCES
- FGF23 promotes myocardial fibrosis in mice through activation of β-catenin
- (2016) Huixin Hao et al. Oncotarget
- Association between FGF23, α-Klotho, and Cardiac Abnormalities among Patients with Various Chronic Kidney Disease Stages
- (2016) Suguru Tanaka et al. PLoS One
- Fibroblast Growth Factor 23 and the Antiproteinuric Response to Dietary Sodium Restriction During Renin-Angiotensin-Aldosterone System Blockade
- (2015) Jelmer K. Humalda et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Activation of Cardiac Fibroblast Growth Factor Receptor 4 Causes Left Ventricular Hypertrophy
- (2015) Alexander Grabner et al. Cell Metabolism
- Immune Cell and Other Noncardiomyocyte Regulation of Cardiac Hypertrophy and Remodeling
- (2015) R. A. Frieler et al. CIRCULATION
- Experimental Myocardial Infarction Upregulates Circulating Fibroblast Growth Factor-23
- (2015) Olena Andrukhova et al. JOURNAL OF BONE AND MINERAL RESEARCH
- The failing heart is a major source of circulating FGF23 via oncostatin M receptor activation
- (2015) Manfred Richter et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Normal 25-Hydroxyvitamin D Levels Are Associated with Less Proteinuria and Attenuate Renal Failure Progression in Children with CKD
- (2015) R. Shroff et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Induction of cardiac FGF23/FGFR4 expression is associated with left ventricular hypertrophy in patients with chronic kidney disease
- (2015) Maren Leifheit-Nestler et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Elevation of circulating but not myocardial FGF23 in human acute decompensated heart failure
- (2015) Ingrid A. Andersen et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Careless talk costs lives: fibroblast growth factor receptor signalling and the consequences of pathway malfunction
- (2015) Edward P. Carter et al. TRENDS IN CELL BIOLOGY
- The Fibroblast Growth Factor signaling pathway
- (2015) David M. Ornitz et al. Wiley Interdisciplinary Reviews-Developmental Biology
- Association of Fibroblast Growth Factor-23 Levels and Angiotensin-Converting Enzyme Inhibition in Chronic Systolic Heart Failure
- (2015) Peter Wohlfahrt et al. JACC-Heart Failure
- Pathophysiological impact of serum fibroblast growth factor 23 in patients with nonischemic cardiac disease and early chronic kidney disease
- (2014) Miki Imazu et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Fibroblast Growth Factor-23 and Cardiovascular Disease in the General Population
- (2014) Bryan Kestenbaum et al. Circulation-Heart Failure
- Coupling fibroblast growth factor 23 production and cleavage
- (2014) Myles Wolf et al. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
- Anti-fibroblast growth factor 23 antibody therapy
- (2014) Seiji Fukumoto CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
- Fibroblast Growth Factor-23, Cardiovascular Prognosis, and Benefit of Angiotensin-Converting Enzyme Inhibition in Stable Ischemic Heart Disease
- (2014) Jacob A. Udell et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Renal expression of FGF23 and peripheral resistance to elevated FGF23 in rodent models of polycystic kidney disease
- (2014) Daniela Spichtig et al. KIDNEY INTERNATIONAL
- Roles of phosphate and fibroblast growth factor 23 in cardiovascular disease
- (2014) Julia J. Scialla et al. Nature Reviews Nephrology
- FGF23 protein expression in coronary arteries is associated with impaired kidney function
- (2014) Natalie A. van Venrooij et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Plasma FGF23 and the risk of stroke: The Northern Manhattan Study (NOMAS)
- (2014) C. B. Wright et al. NEUROLOGY
- Dynamic regulation of FGF23 by Fam20C phosphorylation, GalNAc-T3 glycosylation, and furin proteolysis
- (2014) V. S. Tagliabracci et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Fibroblast Growth Factor–23 and Cardiac Structure and Function
- (2014) Isha Agarwal et al. Journal of the American Heart Association
- FGF23 is a novel regulator of intracellular calcium and cardiac contractility in addition to cardiac hypertrophy
- (2013) Chad D. Touchberry et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- The Associations of Fibroblast Growth Factor 23 and Uncarboxylated Matrix Gla Protein With Mortality in Coronary Artery Disease: The Heart and Soul Study
- (2013) Benjamin D. Parker ANNALS OF INTERNAL MEDICINE
- Fibroblast Growth Factor 23 and Cardiovascular Mortality after Kidney Transplantation
- (2013) L. C. Baia et al. Clinical Journal of the American Society of Nephrology
- Loss of Klotho Contributes to Kidney Injury by Derepression of Wnt/ -Catenin Signaling
- (2013) L. Zhou et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Fibroblast growth factor 23 is not associated with and does not induce arterial calcification
- (2013) Julia J. Scialla et al. KIDNEY INTERNATIONAL
- Exploring mechanisms of FGF signalling through the lens of structural biology
- (2013) Regina Goetz et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- The Role of Fibroblast Growth Factor-23 in Cardiorenal Syndrome
- (2013) Csaba P. Kovesdy et al. NEPHRON CLINICAL PRACTICE
- Associations between fibroblast growth factor 23 and cardiac characteristics in pediatric heart failure
- (2013) Tamara Isakova et al. PEDIATRIC NEPHROLOGY
- Association between Circulating Fibroblast Growth Factor 23, α-Klotho, and the Left Ventricular Ejection Fraction and Left Ventricular Mass in Cardiology Inpatients
- (2013) Kensaku Shibata et al. PLoS One
- Renal Expression of FGF23 in Progressive Renal Disease of Diabetes and the Effect of Ace Inhibitor
- (2013) Cristina Zanchi et al. PLoS One
- Pathophysiological roles of FGF signaling in the heart
- (2013) Nobuyuki Itoh et al. Frontiers in Physiology
- Fibroblast Growth Factor 23 and Inflammation in CKD
- (2012) J. Munoz Mendoza et al. Clinical Journal of the American Society of Nephrology
- Fibroblast growth factor 23 and the heart
- (2012) Christian Faul CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
- Nuclear fibroblast growth factor 2 (FGF2) isoforms inhibit bone marrow stromal cell mineralization through FGF23/FGFR/MAPK in vitro
- (2012) Liping Xiao et al. JOURNAL OF BONE AND MINERAL RESEARCH
- FGF23 neutralization improves chronic kidney disease–associated hyperparathyroidism yet increases mortality
- (2012) Victoria Shalhoub et al. JOURNAL OF CLINICAL INVESTIGATION
- Higher fibroblast growth factor-23 increases the risk of all-cause and cardiovascular mortality in the community
- (2012) Johan Ärnlöv et al. KIDNEY INTERNATIONAL
- Skeletal secretion of FGF-23 regulates phosphate and vitamin D metabolism
- (2012) L. Darryl Quarles Nature Reviews Endocrinology
- FGF-23: the rise of a novel cardiovascular risk marker in CKD
- (2012) G. H. Heine et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Fibroblast growth factor 23 and left ventricular hypertrophy in children on dialysis
- (2012) Wacharee Seeherunvong et al. PEDIATRIC NEPHROLOGY
- A Comparative Transcriptome Analysis Identifying FGF23 Regulated Genes in the Kidney of a Mouse CKD Model
- (2012) Bing Dai et al. PLoS One
- Signaling network of Oncostatin M pathway
- (2012) Gourav Dey et al. Journal of Cell Communication and Signaling
- Oncostatin M Is a Major Mediator of Cardiomyocyte Dedifferentiation and Remodeling
- (2011) Thomas Kubin et al. Cell Stem Cell
- β-catenin signaling
- (2011) Anna P. Lam et al. CURRENT OPINION IN RHEUMATOLOGY
- The phosphatonin fibroblast growth factor 23 links calcium–phosphate metabolism with left-ventricular dysfunction and atrial fibrillation
- (2011) Sarah Seiler et al. EUROPEAN HEART JOURNAL
- Fibroblast Growth Factor 23 and Risks of Mortality and End-Stage Renal Disease in Patients With Chronic Kidney Disease
- (2011) Tamara Isakova JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Fibroblast growth factors: from molecular evolution to roles in development, metabolism and disease
- (2011) N. Itoh et al. JOURNAL OF BIOCHEMISTRY
- FGF23 induces left ventricular hypertrophy
- (2011) Christian Faul et al. JOURNAL OF CLINICAL INVESTIGATION
- Intramyocardial Fibroblast Myocyte Communication
- (2010) Rahul Kakkar et al. CIRCULATION RESEARCH
- Fibroblast growth factor (FGF)-23 and fetuin-A in calcified carotid atheroma
- (2010) Mathias Voigt et al. HISTOPATHOLOGY
- FGF-23 and vascular dysfunction in patients with stage 3 and 4 chronic kidney disease
- (2010) Mahmut I. Yilmaz et al. KIDNEY INTERNATIONAL
- Research Resource: Comprehensive Expression Atlas of the Fibroblast Growth Factor System in Adult Mouse
- (2010) Klementina Fon Tacer et al. MOLECULAR ENDOCRINOLOGY
- Serum fibroblast growth factor-23 (FGF-23) levels are independently associated with left ventricular mass and myocardial performance index in maintenance haemodialysis patients
- (2010) A. Kirkpantur et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Fibroblast growth factor-23 (FGF-23) is independently correlated to aortic calcification in haemodialysis patients
- (2010) M. M. Nasrallah et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- FGF-23 and future cardiovascular events in patients with chronic kidney disease before initiation of dialysis treatment
- (2010) S. Seiler et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Hemodialysis
- (2010) Jonathan Himmelfarb et al. NEW ENGLAND JOURNAL OF MEDICINE
- Fibroblast Growth Factor 23: A Possible Cause of Left Ventricular Hypertrophy in Hemodialysis Patients
- (2009) Heng Jung Hsu et al. AMERICAN JOURNAL OF THE MEDICAL SCIENCES
- Circulating fibroblast growth factor-23 is associated with vascular dysfunction in the community
- (2009) Majd A.I. Mirza et al. ATHEROSCLEROSIS
- Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population
- (2009) Majd A.I. Mirza et al. ATHEROSCLEROSIS
- Fibroblast Growth Factor 23 and Left Ventricular Hypertrophy in Chronic Kidney Disease
- (2009) Orlando M. Gutiérrez et al. CIRCULATION
- Nuclear Isoforms of Fibroblast Growth Factor 2 Are Novel Inducers of Hypophosphatemia via Modulation of FGF23 and KLOTHO
- (2009) Liping Xiao et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Oncostatin M Receptor-β Mutations Underlie Familial Primary Localized Cutaneous Amyloidosis
- (2008) Ken Arita et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Fibroblast Growth Factor 23 and Mortality among Patients Undergoing Hemodialysis
- (2008) Orlando M. Gutiérrez et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started